OSH Stock Overview Oak Street Health, Inc., together with its subsidiaries, provides healthcare services to the patients in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Oak Street Health, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Oak Street Health Historical stock prices Current Share Price US$39.00 52 Week High US$39.00 52 Week Low US$13.29 Beta 2.23 1 Month Change 0.41% 3 Month Change 42.44% 1 Year Change 92.78% 3 Year Change n/a 5 Year Change n/a Change since IPO -2.50%
Recent News & Updates
Chief Innovation Officer & Director notifies of intention to sell stock Apr 21
Chief Financial Officer recently sold US$232k worth of stock Apr 14
Chief Innovation Officer & Director notifies of intention to sell stock Apr 03
Chief Innovation Officer & Director notifies of intention to sell stock Mar 20
Chief Innovation Officer & Director notifies of intention to sell stock Mar 12
Chief Innovation Officer & Director recently sold US$274k worth of stock Mar 02 See more updates
Chief Innovation Officer & Director notifies of intention to sell stock Apr 21
Chief Financial Officer recently sold US$232k worth of stock Apr 14
Chief Innovation Officer & Director notifies of intention to sell stock Apr 03
Chief Innovation Officer & Director notifies of intention to sell stock Mar 20
Chief Innovation Officer & Director notifies of intention to sell stock Mar 12
Chief Innovation Officer & Director recently sold US$274k worth of stock Mar 02
Full year 2022 earnings: EPS misses analyst expectations Mar 01
Chief Innovation Officer & Director notifies of intention to sell stock Feb 26
Chief Innovation Officer & Director notifies of intention to sell stock Feb 12
CVS Health Corporation (NYSE:CVS) entered into a definitive agreement to acquire Oak Street Health, Inc. (NYSE:OSH) from Newlight Partners LP, General Atlantic LLC and others for $9.6 billion. Feb 10
Price target increased by 8.5% to US$35.00 Feb 09 CVS Health Corporation (NYSE:CVS) entered into a definitive agreement to acquire Oak Street Health, Inc. (NYSE:OSH) from Newlight Partners LP, General Atlantic LLC and others for $9.6 billion. Feb 09
CVS close to acquiring Oak Street Health for $10.5B - WSJ Feb 07
Chief Legal Officer & Secretary notifies of intention to sell stock Feb 02
Chief Innovation Officer & Director notifies of intention to sell stock Jan 14 CVS Reportedly Explores an Acquisition of Oak Street Health Jan 11
Oak Street Health jumps on report of CVS takeover interest Jan 09
Chief Operating Officer notifies of intention to sell stock Jan 08
Oak Street Health, Inc. Appoints Deb Edberg as First Chief Wellness Officer Jan 07
Chief Innovation Officer & Director notifies of intention to sell stock Dec 12
Chief Operating Officer notifies of intention to sell stock Dec 09 Oak Street Health, Inc. announced that it has received funding Nov 17
Oak Street Health pares gain on report about takeover chances Nov 16
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Nov 08
Oak Street Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2022 Nov 08
Oak Street Health Q3 2022 Earnings Preview Nov 07
Chief Operating Officer notifies of intention to sell stock Nov 05
Oak Street Health, Inc. to Report Q3, 2022 Results on Nov 07, 2022 Oct 12
Chief Operating Officer notifies of intention to sell stock Oct 07
Board Member notifies of intention to sell stock Sep 26
Oak Street Health Launches Nurse Practitioner Fellowship in Adult Primary Care Sep 21
Oak Street Health downgraded at Goldman Sachs citing cloudy outlook Sep 12
Chief Innovation Officer & Director notifies of intention to sell stock Sep 10
Chief Innovation Officer & Director notifies of intention to sell stock Aug 27
Chief Operating Officer recently sold US$258k worth of stock Aug 21
Oak Street Health, Inc. has completed a Follow-on Equity Offering in the amount of $180.25 million. Aug 19 Oak Street Health, Inc. has completed a Follow-on Equity Offering in the amount of $180.25 million. Aug 17
Oak Street Health slips aftermarket on secondary stock offering Aug 16
Consensus forecasts updated Aug 10
CEO & Chairman notifies of intention to sell stock Aug 07
Price target increased to US$31.78 Aug 05
Second quarter 2022 earnings: EPS misses analyst expectations Aug 03
Oak Street Health, Inc. Provides Earnings Guidance for the Three Months Ending September 30, 2022 and Twelve Months Ending December 31, 2022 Aug 03
Oak Street Health Q2 2022 Earnings Preview Aug 01
Chief Innovation Officer & Director notifies of intention to sell stock Jul 25
Chief Innovation Officer & Director notifies of intention to sell stock Jul 16
Oak Street Health, Inc. to Report Q2, 2022 Results on Aug 02, 2022 Jul 15
Chief Innovation Officer & Director notifies of intention to sell stock Jul 02
Chief Innovation Officer & Director notifies of intention to sell stock Jun 04
Chief Innovation Officer & Director notifies of intention to sell stock May 07
Oak Street Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2022 and for the Full Year Ending December 31, 2022 May 05
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 04
Chief Innovation Officer & Director notifies of intention to sell stock Apr 27
Chief Innovation Officer & Director notifies of intention to sell stock Apr 23
Oak Street Health, Inc. to Report Q1, 2022 Results on May 03, 2022 Apr 20
Chief Innovation Officer & Director notifies of intention to sell stock Apr 09
Full year 2021 earnings: EPS exceeds analyst expectations Mar 02
Jakubowitz Law Commences Securities Fraud Class Action Lawsuit on Behalf of Shareholders of Oak Street Health, Inc Feb 12
Oak Street Health, Inc. to Report Q4, 2021 Results on Feb 28, 2022 Feb 08
Price target decreased to US$46.00 Jan 27
Chief Innovation Officer & Director notifies of intention to sell stock Jan 16
Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Oak Street Health, Inc Jan 12
Price target decreased to US$50.38 Jan 12
President notifies of intention to sell stock Jan 09
Chief Innovation Officer & Director notifies of intention to sell stock Jan 01
Oak Street Health Grows Revenue But Struggles With Higher Medical Costs Dec 22
COO & Director exercised options to buy US$161k worth of stock. Dec 22
Chief Legal Officer & Secretary exercised options and sold US$210k worth of stock Dec 14
Oak Street Health: Poised For Growth Following RubiconMD Deal Dec 01
Chairman & CEO notifies of intention to sell stock Nov 21
Chairman & CEO notifies of intention to sell stock Nov 21
Third quarter 2021 earnings released: US$0.49 loss per share (vs US$0.15 loss in 3Q 2020) Nov 10
Chairman & CEO notifies of intention to sell stock Nov 06
COO & Director notifies of intention to sell stock Nov 01
Chairman & CEO notifies of intention to sell stock Oct 23
COO & Director notifies of intention to sell stock Oct 16
Chairman & CEO notifies of intention to sell stock Oct 10
COO & Director notifies of intention to sell stock Oct 02
COO & Director notifies of intention to sell stock Sep 18
High number of new directors Sep 13
Chairman & CEO notifies of intention to sell stock Sep 11
High number of new directors Sep 10
Independent Director Carl Daley has left the company Sep 08
Chairman & CEO notifies of intention to sell stock Sep 04
COO & Director notifies of intention to sell stock Aug 28
Chairman & CEO notifies of intention to sell stock Aug 21
Consensus forecasts updated Aug 12 Shareholder Returns OSH US Healthcare US Market 7D 0.1% -1.5% -2.8% 1Y 92.8% -12.9% 24.1%
See full shareholder returns
Return vs Market: OSH exceeded the US Market which returned -4.2% over the past year.
Price Volatility Is OSH's price volatile compared to industry and market? OSH volatility OSH Average Weekly Movement 8.9% Healthcare Industry Average Movement 7.6% Market Average Movement 6.3% 10% most volatile stocks in US Market 18.0% 10% least volatile stocks in US Market 3.1%
Stable Share Price: OSH's share price has been volatile over the past 3 months.
Volatility Over Time: OSH's weekly volatility (9%) has been stable over the past year.
About the Company Oak Street Health, Inc., together with its subsidiaries, provides healthcare services to the patients in the United States. It operates primary care centers for Medicare beneficiaries in Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Show more Oak Street Health, Inc. Fundamentals Summary How do Oak Street Health's earnings and revenue compare to its market cap? OSH fundamental statistics Market cap US$9.53b Earnings (TTM ) -US$509.20m Revenue (TTM ) US$2.16b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) OSH income statement (TTM ) Revenue US$2.16b Cost of Revenue US$2.08b Gross Profit US$78.10m Other Expenses US$587.30m Earnings -US$509.20m
Last Reported Earnings
Dec 31, 2022
Earnings per share (EPS) -2.08 Gross Margin 3.61% Net Profit Margin -23.56% Debt/Equity Ratio -366.1%
How did OSH perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2023/05/03 15:09 End of Day Share Price 2023/05/01 00:00 Earnings 2022/12/31 Annual Earnings 2022/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Oak Street Health, Inc. is covered by 22 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Matthew Gillmor Baird Sarah James Barclays Kevin Fischbeck BofA Global Research
Show 19 more analysts 
